Matches in Wikidata for { <http://www.wikidata.org/entity/Q64363995> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- Q64363995 description "assaig clínic" @default.
- Q64363995 description "clinical trial" @default.
- Q64363995 description "clinical trial" @default.
- Q64363995 description "clinical trial" @default.
- Q64363995 description "clinical trial" @default.
- Q64363995 description "ensaio clínico" @default.
- Q64363995 description "ensayo clínico" @default.
- Q64363995 description "ensayu clínicu" @default.
- Q64363995 description "essai clinique" @default.
- Q64363995 description "klinisch onderzoek" @default.
- Q64363995 description "клінічне випробування" @default.
- Q64363995 name "Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)" @default.
- Q64363995 type Item @default.
- Q64363995 label "Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)" @default.
- Q64363995 prefLabel "Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)" @default.
- Q64363995 P1050 Q64363995-4ABA2D45-4CF1-4C7F-8F70-B01C12391C26 @default.
- Q64363995 P1132 Q64363995-7B4584A4-3409-4B85-BE2D-1AA01C50EF57 @default.
- Q64363995 P1476 Q64363995-9C1B526B-E1EC-495E-AFE3-F9B0D203B432 @default.
- Q64363995 P17 Q64363995-048C5C49-046E-4C68-B5FC-03454652BEA7 @default.
- Q64363995 P17 Q64363995-3423C870-0E1A-48C1-8848-298221068E48 @default.
- Q64363995 P17 Q64363995-40932CC9-5E8A-4DE3-A04D-BF5C321C0072 @default.
- Q64363995 P17 Q64363995-4A7AF542-83B4-4032-9DB7-3CBD32FA8CA3 @default.
- Q64363995 P17 Q64363995-4BC8142C-BB62-4AFA-BB3D-37913F3F6CC7 @default.
- Q64363995 P17 Q64363995-99FCADDF-D4F3-4351-A3C3-8D92DE67B8A5 @default.
- Q64363995 P17 Q64363995-DB54173C-DEAA-481B-A75A-CFECAD960B93 @default.
- Q64363995 P2899 Q64363995-E2165136-60F0-463D-9C89-7CFF607EE872 @default.
- Q64363995 P3098 Q64363995-66ED1AAD-E3F7-41E5-87A9-92E137ED19FB @default.
- Q64363995 P31 Q64363995-89146121-D159-44F7-9DDC-F4D096853F0B @default.
- Q64363995 P4844 Q64363995-1A0EE7A0-2AE0-4C92-8C14-18AFB42C5361 @default.
- Q64363995 P580 Q64363995-214205FD-EE61-474D-BAF8-09A0A877C6C9 @default.
- Q64363995 P582 Q64363995-84EC0E9E-3648-4523-8737-DEF94D812914 @default.
- Q64363995 P6099 Q64363995-37D612D9-174F-465E-941D-A79B660FBB34 @default.
- Q64363995 P6153 Q64363995-08B982AB-4DA4-4654-9A79-56B80DD97C84 @default.
- Q64363995 P6153 Q64363995-09DBCDBF-946D-4958-8D60-45677C95DA12 @default.
- Q64363995 P6153 Q64363995-0A7C6D45-5457-44D8-96D3-D26824C1D9D0 @default.
- Q64363995 P6153 Q64363995-155E8374-D5D0-4568-8209-89D0FE90AA02 @default.
- Q64363995 P6153 Q64363995-3B512EF4-B6BF-4FB6-8277-DA109916D6D1 @default.
- Q64363995 P6153 Q64363995-451FB444-A318-4A69-80D7-9569C4FBFE66 @default.
- Q64363995 P6153 Q64363995-586D6C03-3CDB-4458-87D2-289F3093D217 @default.
- Q64363995 P6153 Q64363995-63F68422-C79D-4AA5-A80F-4A2F93CF3B61 @default.
- Q64363995 P6153 Q64363995-65890224-DD31-4A25-A10D-02C40E61244D @default.
- Q64363995 P6153 Q64363995-683A35F4-37AA-4D75-9185-A2ACCD2DC9E2 @default.
- Q64363995 P6153 Q64363995-76FBCB82-852D-4F65-8936-9E8F3986A4D0 @default.
- Q64363995 P6153 Q64363995-7FEC3AFE-8E93-4A90-9F46-89A567D5CE8F @default.
- Q64363995 P6153 Q64363995-8FB50F83-FD7E-46D1-A96B-8C001DF22A94 @default.
- Q64363995 P6153 Q64363995-924D7AD7-8AF9-4BD0-A5EF-1E73FC03B387 @default.
- Q64363995 P6153 Q64363995-A67F4F0D-920F-4653-AFC1-38C926431C3C @default.
- Q64363995 P6153 Q64363995-A743A411-E304-4180-8A0E-ACB0945968E6 @default.
- Q64363995 P6153 Q64363995-A937AD3C-2D13-47D4-AB5C-796B20B774EC @default.
- Q64363995 P6153 Q64363995-AD422A4B-1F13-4414-AD5D-5F080F46FD4E @default.
- Q64363995 P6153 Q64363995-E9F05CEF-B292-4AC6-B1A8-1E66DD3E65E8 @default.
- Q64363995 P6153 Q64363995-EA10E98F-64F0-4548-9220-FA5ED222D371 @default.
- Q64363995 P6153 Q64363995-EB01CBF2-90A7-4872-B77B-DE4A72C5E369 @default.
- Q64363995 P6153 Q64363995-FF188D1C-26BD-49A4-A57B-C48A1802BC59 @default.
- Q64363995 P8363 Q64363995-F67D42A8-DC9D-4739-B534-C64A88D1520F @default.
- Q64363995 P1050 Q356033 @default.
- Q64363995 P1132 "+430" @default.
- Q64363995 P1476 "A Randomized, Multicenter, Double-blind, Placebo-controlled, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma" @default.
- Q64363995 P17 Q142 @default.
- Q64363995 P17 Q145 @default.
- Q64363995 P17 Q183 @default.
- Q64363995 P17 Q29 @default.
- Q64363995 P17 Q30 @default.
- Q64363995 P17 Q31 @default.
- Q64363995 P17 Q38 @default.
- Q64363995 P2899 "+18" @default.
- Q64363995 P3098 "NCT02436668" @default.
- Q64363995 P31 Q30612 @default.
- Q64363995 P4844 Q423762 @default.
- Q64363995 P580 "2015-05-01T00:00:00Z" @default.
- Q64363995 P582 "2018-10-01T00:00:00Z" @default.
- Q64363995 P6099 Q42824827 @default.
- Q64363995 P6153 Q1052562 @default.
- Q64363995 P6153 Q27892167 @default.
- Q64363995 P6153 Q30279623 @default.
- Q64363995 P6153 Q30281511 @default.
- Q64363995 P6153 Q3145371 @default.
- Q64363995 P6153 Q3344269 @default.
- Q64363995 P6153 Q3747180 @default.
- Q64363995 P6153 Q39997 @default.
- Q64363995 P6153 Q4403855 @default.
- Q64363995 P6153 Q4803501 @default.
- Q64363995 P6153 Q49212 @default.
- Q64363995 P6153 Q5263135 @default.
- Q64363995 P6153 Q5902531 @default.
- Q64363995 P6153 Q624119 @default.
- Q64363995 P6153 Q7401561 @default.
- Q64363995 P6153 Q7451677 @default.
- Q64363995 P6153 Q7569131 @default.
- Q64363995 P6153 Q81172471 @default.
- Q64363995 P6153 Q81949 @default.
- Q64363995 P6153 Q833670 @default.
- Q64363995 P6153 Q89798279 @default.
- Q64363995 P6153 Q9004969 @default.
- Q64363995 P8363 Q78089383 @default.